Structural complexity of the testis and PKG I / StAR interaction regulate the Leydig cell adaptive response to repeated immobilization stress.
The role of the structural complexity of the testis and the nitric oxide (NO)-cyclic guanosine monophosphate (cGMP) signalling pathway was analysed in adult male rats exposed to acute and repeated immobilization stress (IMO). In whole testis preparations, exposure to acute and repeated IMO caused an increase in NO production. In contrast, NO production was inhibited in interstitial cell preparations after exposure to all types of stress. In purified Leydig cell preparations, NO production was inhibited only after exposure to prolonged IMO. These findings indicate that biologically active compounds released from various testicular compartments exert both stimulatory and inhibitory effects on NO production. TaqMan Low Density Array of rat phosphodiesterases revealed a decrease in the expression of cGMP-specific phosphodiesterase 5 (PDE5) in Leydig cells of animals exposed to repeated IMO. In contrast, the expression of cGMP-dependent protein kinase type I (PKG I), total and phosphorylated steroidogenic acute regulatory protein (StAR), and PKG I/StAR immunoprecipitated complex was increased during repeated exposure to IMO. The increase in both total and phosphorylated StAR formation was effectively blocked by inhibition of PKG I in vitro. Thus, increased expressions of PKG I and StAR complex, accompanied by decreased PDE5 activity, suggest that the NO-cGMP signalling pathway and consequent activation of the StAR protein regulate the adaptive response of Leydig cells to repeated IMO stress.
Kostic
T S
TS
Laboratory for Reproductive Endocrinology and Signaling, Faculty of Sciences, University of Novi Sad, Novi Sad, Serbia.
Stojkov
N J
NJ
Janjic
M M
MM
Andric
S A
SA
D000728:Androgens / Q000096:biosynthesis; D000818:Animals; D002478:Cells, Cultured; D017869:Cyclic GMP-Dependent Protein Kinases / Q000037:antagonists & inhibitors / Q000502:physiology*; D054706:Cyclic Nucleotide Phosphodiesterases, Type 5 / Q000096:biosynthesis*; D007985:Leydig Cells / Q000378:metabolism*; D008297:Male; D009569:Nitric Oxide / Q000502:physiology*; D010750:Phosphoproteins / Q000502:physiology*; D011374:Progesterone / Q000096:biosynthesis; D051381:Rats; D017208:Rats, Wistar; D012149:Restraint, Physical; D015398:Signal Transduction / Q000502:physiology*; D013312:Stress, Physiological; D013737:Testis / Q000378:metabolism*; D000098682:Steroidogenic Acute Regulatory Protein
D000728:Androgens; D010750:Phosphoproteins; D000098682:Steroidogenic Acute Regulatory Protein; D009569:Nitric Oxide; D011374:Progesterone; D017869:Cyclic GMP-Dependent Protein Kinases; D054706:Cyclic Nucleotide Phosphodiesterases, Type 5